[Effects of delta sleep-inducing peptide on electrophysiological parameters of sleep during alcohol withdrawal in rats].
Viglinskaia. I V IV; Salimov. R M RM; Maĭskiĭ. A I AI
Key Findings
- Alcohol withdrawal in rats worsened sleep: reduced slow‑wave sleep, more awakenings, and poorer sleep depth.
- Rats showed two patterns during alcohol intake—some had less REM sleep, others had more REM sleep.
- A single dose of DSIP (0.1 mg/kg, i.p.) given one hour before sleep reduced the withdrawal‑induced sleep disruptions.
- The effect was observed across both REM‑deficit and REM‑abundance groups, normalizing their sleep patterns.
Practical Outcomes
- For biohackers interested in managing alcohol withdrawal, DSIP shows promise as a sleep‑stabilizing agent, but the evidence is limited to animal models. Until human data are available, it should be considered experimental and not a ready‑to‑use protocol. If you are exploring DSIP, start with very low doses and monitor sleep quality closely, keeping in mind the lack of safety and efficacy data in people.
Summary
In rats that drink alcohol, stopping the alcohol caused big sleep problems, like less deep sleep and more awakenings. Giving them a tiny dose of delta sleep‑inducing peptide (DSIP) before bedtime helped smooth out these sleep disturbances. The study suggests DSIP might be useful for easing sleep issues during alcohol withdrawal, but it was only tested in rats.
Abstract
In rats with the persistent alcohol motivation the electrophysiological sleep pattern was studied during ethanol intake, after 24 and 48 hours of alcohol withdrawal. It was established that during the voluntary ethanol intake rats may be divided into two groups: with comparative deficit (1st group) and comparative abundance (2nd group) of REM sleep. Alcohol withdrawal caused differential alterations of sleep-wakefulness cycle: in the 1st group of rats REM sleep was more suppressed while in the 2nd group--more increased in comparison to those during ethanol intake. In all animals the SWS depression, increase of awakenings, the aggravation of falling asleep and decrease of sleep depth were observed. DSIP (0.1 mg/kg, i.p. 1 hour before sleep recording) was found to regulate sleep disorders caused by ethanol withdrawal. It makes the neuropeptide possible to be recommended for ethanol withdrawal syndrome treatment in clinical practice.
Study Information
pubmed
1990